Charlottesville, VA, United States of America

Craig L Slingluff, Jr

USPTO Granted Patents = 7 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2003-2023

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Craig L. Slingluff, Jr.: Innovator in Cancer Treatment and Surgical Techniques

Introduction

Craig L. Slingluff, Jr. is a notable inventor based in Charlottesville, Virginia, recognized for his contributions to the fields of oncology and minimally invasive surgical techniques. With a total of seven patents, Slingluff has focused on innovative solutions that enhance cancer treatment and surgical efficiency.

Latest Patents

Slingluff's most recent patents include groundbreaking work on compositions and methods for treating melanoma. His research reveals that Toll-like receptor (TLR) agonists can induce chemokine production, specifically CXCL10, from human melanoma cells. The findings suggest that TLR2 and TLR6 are significantly expressed on these cells and that the combination of TLR2/6 agonists with interferon-gamma (IFN-γ) creates a novel synergistic effect in enhancing CXCL10 production. This synergy may improve immune responses within melanoma tumors and has potential value when combined with other immune therapies.

Another notable patent by Slingluff describes a device and method for safely expanding minimally invasive surgical incisions. This innovation allows for a more efficient approach to accessing affected organs, ensuring that scalpel usage is both safe and precise, which benefits patient outcomes during surgeries.

Career Highlights

Craig L. Slingluff, Jr. is affiliated with the University of Virginia, where he utilizes his expertise to advance research and development in medical technologies. His career is distinguished by his commitment to improving therapeutic methods and surgical practices, thereby enhancing patient care and treatment efficacy.

Collaborations

Throughout his career, Slingluff has collaborated with esteemed colleagues, including Donald F. Hunt and Victor H. Engelhard. These partnerships have fostered an environment of innovation and have propelled their joint efforts to further understand and combat cancer.

Conclusion

Craig L. Slingluff, Jr. stands out as an influential inventor whose work notably impacts cancer treatment and surgical methodologies. His patents reflect a deep commitment to science and innovation, paving the way for advancements in medical technology that will benefit both practitioners and patients in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…